| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10053018 | The Journal of Urology | 2005 | 6 Pages |
Abstract
In elderly volunteers 2 weeks of treatment with darifenacin had no effect on cognitive function compared with baseline and it was not significantly different from placebo. This may be related to its M3 receptor selectivity with negligible M1 receptor antagonism.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
RICHARD B. LIPTON, KEN KOLODNER, KEITH WESNES,